# Research Manager Report - MPL.AX

## Tool Outputs Used
- Analyst reports for market, sentiment, news, fundamentals, financial report, and industry/theme discovery.
- Debate reports from Bull and Bear researchers.

## Primary Rating Driver
Primary rating driver: sector_metric

Market technicals are treated as a confidence and timing modifier, not as the main investment-rating engine.

## Evidence Winner
Adverse sector-specific metrics outweigh supportive evidence: 5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only, 2 available / 0 gap-labelled core sections, with membership (financial:MPL.AX:2026-07-02:018) as the clearest adverse/quality reference.

## Structured Evidence Matrix
| Role | Evidence ID | Direction | Materiality | Confidence | Tool output | Weight | Reason | Independence group ID |
|---|---|---|---|---|---|---:|---|---|
| Market Analyst | market:MPL.AX:2026-07-02:001 | positive | high | medium | market snapshot | +1 | Underweight is driven by sector_metric: Adverse sector-specific metrics outweigh supportive evidence: 5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only, 2 available / 0 gap-labelled core sections, with membership (financial:MPL.AX:2026-07-02:018) as the clearest adverse/quality reference. Market setup is a confidence/timing modifier only: latest close 4.99 is above the 10 EMA (4.94), above the 50 SMA (4.77), and above the 200 SMA (4.63). Trend score +2 changes Trader timing and Research Manager confidence, but it is not the evidence winner. | market:MPL.AX:2026-07-02:trend |
| Financial Report Analyst | financial:MPL.AX:2026-07-02:001 | positive | high | medium | filing section extraction | +2 | ASX document and sector-metric records support financial review with gaps disclosed | event:MPL.AX:2026-07-02:financial-report |
| News Analyst | news:MPL.AX:2026-07-02:001 | positive | medium | medium | article evidence card | +1 | Direct company evidence, not repeated snippet-only headlines | event:MPL.AX:2026-07-02:earnings |
| Sentiment Analyst | social:MPL.AX:2026-07-02:001 | mixed | low | low | social summary | 0 | Retail-only reaction is noisy and not independent fundamental evidence | reaction:MPL.AX:2026-07-02:retail |
| Bear Researcher | fundamentals:MPL.AX:2026-07-02:001 | negative | medium | medium | fundamentals packet | -1 | Valuation/timing risk keeps action from becoming aggressive | risk:MPL.AX:2026-07-02:valuation-trend |

Score calculation / component weights: Sector metric direction mix (5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only), +1 official financial-report sections (2 available / 0 gap-labelled core sections), +2 market setup as timing/confidence modifier (positive across 10 EMA, 50 SMA, and 200 SMA), -1 evidence-gap/source-depth cap, 0 retail sentiment = Underweight driven by sector_metric.

## Role Evidence Weighting
- Financial report / sector metrics: primary evidence group for ASX where available; filing and fundamentals evidence is not counted again through Bull/Bear restatement.
- Market technicals: capped timing/confidence modifier.
- News: contextual event evidence unless a direct material event is identified.
- Sentiment: low-confidence retail reaction with zero standalone decision weight.

## Rating Rationale
**Recommendation**: Underweight

Underweight beats Hold because health_insurers sector metrics include multiple adverse directional readings. Trader still decides whether Sell timing is confirmed. The earnings/news/social style of evidence is grouped by independence ID so repeated role mentions do not become separate support. Rating-vs-rating selection was explicitly considered; social sentiment alone has zero decision weight.

## Rating-vs-Rating Reasoning
1. Why not Buy / Overweight? Buy/Overweight is not selected because adverse metric direction is too prominent (2 adverse versus 1 supportive).
2. Why not Sell / Underweight? Sell is not selected by Research Manager because Sell is reserved for a completed negative investment case; Trader must separately confirm a Sell setup.
3. Which role evidence was decisive? Decisive role evidence is Financial Report Analyst / ASX sector metrics (financial:MPL.AX:2026-07-02:018) plus Fundamentals/Financial section context; Market Analyst (market:MPL.AX:2026-07-02:001, market:MPL.AX:2026-07-02:002, market:MPL.AX:2026-07-02:003, market:MPL.AX:2026-07-02:004) modifies timing; News (news:MPL.AX:2026-07-02:001) is contextual and Sentiment is low weight.
4. Which sector-specific financial metrics mattered? health_insurers metric direction mix: 5 available / 0 gap-labelled; 1 supportive, 2 adverse, 0 mixed, 2 neutral, 0 context-only. supportive examples: membership (supportive, financial:MPL.AX:2026-07-02:018); adverse examples: premium growth (adverse, financial:MPL.AX:2026-07-02:016); claims ratio (adverse, financial:MPL.AX:2026-07-02:017); mixed/neutral examples: capital adequacy (neutral, financial:MPL.AX:2026-07-02:019); operating profit (neutral, financial:MPL.AX:2026-07-02:020). Highlighted metric: membership is available / supportive via financial:MPL.AX:2026-07-02:018.
5. Which evidence gaps capped confidence? Confidence is capped by 0 unavailable sector metric/gap labels, 0 unavailable core financial sections, low-confidence retail sentiment from social:MPL.AX:2026-07-02:001, and medium-confidence extraction depth.
6. How market setup changed the final rating. Market setup is a confidence/timing modifier only: latest close 4.99 is above the 10 EMA (4.94), above the 50 SMA (4.77), and above the 200 SMA (4.63). Trend score +2 changes Trader timing and Research Manager confidence, but it is not the evidence winner.

## Sector Metric Direction Audit
Direction is based on the extracted phrase, supporting sentence, clean value, and comparison basis below, not metric presence alone. Navigation/page-list snippets are downgraded to low-confidence context-only evidence.

| metric_name | extracted_value_or_phrase | clean_metric_value | value_unit | value_context | metric_value_status | association_score | association_reason | table_mapping_confidence | table_mapping_reason | period_reference | comparison_reference | supporting_sentence | comparison_basis | direction | confidence | confidence_reason | evidence_id | table_title | row_label | column_label | cell_value | source_page | current_period_value | prior_period_value | variance_value | variance_percent | raw_row_text |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| premium_growth | r for the 4th year running. Our Live Better rewards members redeemed around $33 million in rewards points this year, through our program which challenges them to take daily actions | unavailable | unavailable | no high-confidence metric-value association | unavailable | 0 | metric label was not found in extracted text | 0 | no table row mapping available | unavailable | unavailable | r for the 4th year running. | period-over-period wording in extracted filing/report phrase | adverse | low | source extractor confidence is low and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:016 | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| claims_ratio | .5% to 22.5 cents per share. The key reasons for the movements in the Health Insurance and Medibank Health results, as well as net investment income, are outlined in this report. H | 3.3 | % | dense row parsed before next financial row label | value_extracted | 88 | dense row label matched accepted metric label and value was selected from the parsed metric row before the next row label | 88 | dense metric row isolated before next financial row label | variance_percent | prior_period_value | .5% to 22.5 cents per share. | period-over-period wording in extracted filing/report phrase | adverse | medium | source extractor confidence is medium and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:017 | unavailable | claims expense (including risk equalisation) (6,814.6) (6,595.8) 3.3% | variance_percent | 3.3% | unavailable | -6814.6 | -6595.8 | unavailable | 3.3 | claims expense (including risk equalisation) (6,814.6) (6,595.8) 3.3% |
| membership | tomers $1.71b total COVID financial support since 2020 $6.6b total claims paid Medibank journey NPS 12.9 (+2.3) average ahm service NPS 48.0 (+2.0) average customer advocacy +27.9k | 3.1 | % | policyholders near 3.1% | value_extracted | 85 | label-value distance 10 tokens; unit % compatible | 0 | no structured table mapping available | FY2020 | not specified | tomers $1.71b total COVID financial support since 2020 $6.6b total claims paid Medibank journey NPS 12.9 (+2.3) average ahm service NPS 48.0 (+2.0) average customer advocacy +27.9k (+1.4%) net resident policyholder growth +10.5k (+3.1%) net | period-over-period wording in extracted filing/report phrase | supportive | medium | source extractor confidence is medium and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:018 | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| capital_adequacy | dividend Medibank’s capital management objective is to maintain a strong financial risk profile and capacity to pay all eligible customer benefits, invest in the growth of our busi | 250 | $m | capital adequacy near $250 m | value_extracted | 96 | label-value distance 2 tokens; unit $m compatible | 0 | no structured table mapping available | FY2023 | FY2022 | • In June 2023 APRA announced an additional capital adequacy requirement of $250 million for Medibank, with effect from 1 July 2023, following a review of the 2022 cybercrime event. | metric mentioned without explicit comparative baseline | neutral | medium | source extractor confidence is medium and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:019 | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |
| operating_profit_or_margin | advocacy (eNPS) 3,956 employees including 964 health professionals Financial $618.7m (+8.5%) Group underlying net profit after tax 10.2 cps final ordinary dividend fully franked 26 | 741.5 | $m | operating profit near $741.5m | value_extracted | 92 | label-value distance 4 tokens; unit $m compatible | 0 | no structured table mapping available | not specified | not specified | advocacy (eNPS) 3,956 employees including 964 health professionals Financial $618.7m (+8.5%) Group underlying net profit after tax 10.2 cps final ordinary dividend fully franked 26.5% resident policyholder market share $76.7m (+27.0%) Medib | metric mentioned without explicit comparative baseline | neutral | medium | source extractor confidence is medium and direction is based on supporting sentence/comparison basis | financial:MPL.AX:2026-07-02:020 | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable | unavailable |

## Debate Outcome Scorecard
| Field | Outcome |
|---|---|
| Bull evidence quality | medium |
| Bear evidence quality | high |
| Strongest Bull evidence ID | financial:MPL.AX:2026-07-02:001 |
| Strongest Bear evidence ID | fundamentals:MPL.AX:2026-07-02:001 |
| Which side directly answered the other side better? | Bear |
| Which side relied on weaker or duplicated evidence? | Bull relied more on continuation evidence than confirmed downside falsification |
| Which evidence gap matters most? | Confidence is capped by 0 unavailable sector metric/gap labels, 0 unavailable core financial sections, low-confidence retail sentiment from social:MPL.AX:2026-07-02:001, and medium-confidence extraction depth. |
| Debate winner | Bear |
| Rating implication | Underweight |
| Trader implication | timing-gated HOLD |

## Debate Change Assessment
- Pre-debate analyst evidence rating: Underweight.
- Changed by debate? No.
- Explanation: Pre-debate analyst evidence was adverse; debate confirmed Bear evidence quality without turning the research rating into an automatic Sell action.
- Scorecard ID: debate:MPL.AX:2026-07-02:outcome-scorecard

## Market Technicals as Confidence / Timing Modifier
Market setup is a confidence/timing modifier only: latest close 4.99 is above the 10 EMA (4.94), above the 50 SMA (4.77), and above the 200 SMA (4.63). Trend score +2 changes Trader timing and Research Manager confidence, but it is not the evidence winner.

## Evidence Gaps
- No final investment judgment is made by Python. This recommendation is Codex interpretation of collected evidence.
- Social reaction is low confidence and cannot independently drive the rating.

## Memory Update
* Durable facts to retain: This run is a paper-study Codex-session workflow; Python prepared evidence and Codex wrote role interpretation.
* Prior mistake to avoid: Do not let template claims override metric evidence, filing section status, or as-of-date controls.
* Open questions: None for this artifact beyond disclosed evidence gaps.
* Evidence references: market:MPL.AX:2026-07-02:001, financial:MPL.AX:2026-07-02:001, news:MPL.AX:2026-07-02:001
* Staleness / expiry: Evidence is valid only for trade date 2026-07-02; refresh before reuse.
